Growth hormone and selective attention: A review

Neuroscience and Biobehavioral Reviews

Volumn 34, Issue 8, 2010, Pages 1137-1143

  Quik, Elise H ^a   van Dam, P Sytze ^b   Kenemans, J Leon ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Anterior cingulate cortex; Cognitive function; Divided attention; Event related potentials (ERP); Growth hormone (GH); Growth hormone deficiency (GHD); Selective attention

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; PLACEBO;

BRAIN FUNCTION; CINGULATE GYRUS; CLINICAL TRIAL; COGNITION; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HIPPOCAMPUS; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; INTRAUTERINE GROWTH RETARDATION; LATENT PERIOD; MENTAL DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; REVIEW; SELECTIVE ATTENTION; SELF ESTEEM; VERBAL MEMORY; VISUAL MEMORY;

ANIMALS; ATTENTION; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOPITUITARISM;

EID: 77954088290     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2010.01.001     Document Type: Review

References (71)

1. Abi-Dargham A., Mawlawi O., Lombardo I., Gil R., Martinez D., Huang Y., Hwang D., Keilp J., Lisa Kochan L., Van Heertum R., Gorman J.M., Laruelle M. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J. Neurosci. 2002, 22(May (9)):3708-3719.
2. Abs R. Update on the diagnosis of GH deficiency in adults. Eur. J. Endocrinol. 2003, 148(Suppl. 2):S3-S8.
3. Abs, R., Mattsson, A.F., Bengtsson, B., Feldt-Rasmussen, U., Góth, M.I., Koltowska-Häggström, M., Monson, J.P., Verhelst, J., Wilton, P, on behalf of the KIMS Study Group, 2005. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Growth Hormone IGF Res. 15, 349-359.
4. Aleman A., Verhaar H.J., De Haan E.H., De Vries W.R., Samson M.M., Drent M.L., van der Veen E.A., Koppeschaar H.P. Insulin-like growth factor-I and cognitive function in healthy older men. J. Clin. Endocrinol. Metab. 1999, 84:471-475.
5. Aleman A., de Vries W.R., Koppeschaar H.P.F., Osman-Dualeh M., Verhaar H.J.J., Samson M.M., Bol E., de Haan E.H.F. Relationship between circulating levels of sex hormones and insulin-like growth factor-I and fluid intelligence in older men. Exp. Aging Res. 2001, 27:283-291.
6. Aleman A., Torres-Alemán I. Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan. Prog. Neurobiol. 2009, 89:256-265.
7. Almqvist O., Thoren M., Saaf M., Eriksson O. Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: a pilot study. Psychoneuroendocrinology 1986, 11:347-352.
8. Arwert L.I., Deijen J.B., Witlox J., Drent M.L. The influence of growth hormone (GH) substitution on patient-reported outcomes and cognitive functions in GH-deficient patients: a meta-analysis. Growth Horm. IGF Res. 2005, 15:47-54.
9. Aston-Jones G., Cohen J.D. An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu. Rev. Neurosci. 2005, 28:403-450.
10. Baudet M.L., Rattray D., Harvey S. Growth hormone and its receptor in projection neurons of the chick visual system: retinofugal and tectobulbar tracts. Neuroscience 2007, 148:151-163.
11. Baum H.B., Katznelson L., Sherman J.C., et al. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J. Clin. Endocrinol. Metab. 1998, 3184-3189.
12. Biessels G.J., Deary I.J., Ryan C.M. Cognition and diabetes: a lifespan perspective. Lancet Neurol. 2008, 7(2):184-190.
13. Braver T.S., Cohen J.D. Dopamine, cognitive control, and schizophrenia: the gating model. Prog. Brain Res. 1999, 121:327-349.
14. Braverman E.R., Chen T.J.H., Prihoda T.J., Sonntag W., Meshkin B., Downs B.W., Mengucci J.F., Blum S.H., Notaro A., Arcuri V., Varshavskiy M., Blum K. Plasma growth hormones, P300 event-related potential and test variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates. Age (Dordr.) 2007, 29(2):55-67.
15. Canosa L.F., Chang J.P., Peter R.E. Neuroendocrine control of growth hormone in fish. Gen. Comp. Endocrinol. 2007, 151:1-26.
16. Casanueva F.F., Castro A.I., Micic D., Kelestimur F., Dieguez C. New guidelines for the diagnosis of growth hormone deficiency in adults. Horm. Res. 2009, 71(Suppl. 1):112-115.
17. Cherrier M.M., Plymate S., Mohan S., et al. Relationship between testosterone supplementation and insulin-like growth factor-I levels and cognition in healthy older men. Psychoneuroendocrinology 2004, 29:65-82.
18. Cohen J.D., Aston-Jones G., Gilzenrat M.S. A systems-level perspective on attention and cognitive control, guided activation, adaptive gating, conflict monitoring and exploitation versus exploration. Cognitive Neuroscience of Attention 2004, 71-90. Guilford Press, New York. M.I. Posner (Ed.).
19. Corbetta M., Shulman G.L. Control of goal-directed and stimulus-driven attention in the brain. Nat. Rev. Neurosci. 2002, 3:201-214.
20. Cuttler L. The regulation of growth hormone secretion. Endocrinol. Metab. Clin. North Am. 1996, 25(3):541-571.
21. Dattani M., Preece M. Growth hormone deficiency and related disorders: insights into causation, diagnosis, and treatment. Lancet 2004, 363:1977-1987.
22. Degerblad M., Almkvist O., Grunditz R., Hall K., Kaijser L., Knutsson E., Ringertz H., Thoren M. Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinol. (Copenh.) 1990, 185-193.
23. Deijen J.B., de Boer H., van der Veen E.A. Cognitive changes during growth hormone replacement in adult men. Psychoneuroendocrinology 1998, 45-55.
24. di Michele F., Prichep L., John E.R., Chabot R.J. The neurophysiology of attention-deficit/hyperactivity disorder. Int. J. Psychophysiol. 2005, 58(1):81-93. Review.
25. Falleti M.G., Maruff P., Burman P., Harris A. The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature. Psychoneuroendocrinology 2006, 31:681-691.
26. Galassetti P., Davis S.N. Effects of insulin per se on neuroendocrine and metabolic counter-regulatory responses to hypoglycaemia. Clin. Sci. (Lond.) 2000, 99:351-362.
27. García-Tornadú I., Rubinstein M., Gaylinn B.D., Hill D., Arany E., Low M.J., Diaz-Torga G., Becu-Villalobos D. GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin. J. Endocrinol. 2006, 190(3):611-619.
28. Gharib H. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children. Endocr. Pract. 2003, 9(1):64-76.
29. Golgeli A., Tanriverdi F., Suer C., Gokce C., Ozemi C., Bayram F., Kelestimur F. Utility of auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy. Eur. J. Endocrinol. 2004, 150:153-159.
30. Holroyd C.B., Coles G.H. Dorsal anterior cingulate cortex integrates reinforcement history to guide voluntary behavior. Cortex 2008, 44:548-559.
31. Inder W.J., Livesey J.H., Ellis M.J., Evans M.J., Donald R.A. The effect of β-endorphin on basal and insulin-hypoglycaemia stimulated levels of hypothalamic-pituitary-adrenal axis hormones in normal human subjects. Clin. Endocrinol. 1996, 44(1):7-13. (1 p.1/4).
32. Jiang H., Betancourt L., Smith R.G. Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone Secretagogue receptor/dopamine receptor subtype 1 heterodimers molecular endocrinology 2006, 20(8):1772-1785.
33. Johansson J.O., Bengtsson B.A. Central nervous effects of growth hormone. Endocrinol. Metab. 1997, 4(Suppl. B):103-107.
34. 1. J. Clin. Endocrinol. Metab. 1997, 82(4):1195-1201.
35. Kenemans J.L., Smulders F.T., Kok A. Selective processing of two-dimensional visual stimuli in young and old subjects: electrophysiological analysis. Psychophysiology 1995, 32:108-120.
36. Kenemans J.L., Lijffijt M., Camfferman G., Verbaten M.N. Splitsecond sequential selective activation in human secondary visual cortex. J. Cogn. Neurosci. 2002, 14:48-61.
37. Lamberts S.W., van den Beld A.W., van der Lely A.J. The endocrinology of aging. Science 1997, 278:419-424.
38. Lansbergen M.M., Kenemans J.L., van Engeland H. Stroop interference and attention-deficit/hyperactivity disorder: a review and meta-analysis. Neuropsychology 2007, 21(2):251-262.
39. Lansbergen M.M., van Hell E., Kenemans J.L. Impulsivity and conflict in the Stroop task: An ERP study. J. Psychophysiol. 2007, 21(1):33.
40. Lijffijt M., van Dam P.S., Kenemans J.L., Koppeschaar H.P., de Vries W.R., Drent M.L., Wittenberg A., Kemner C. Somatotropic-axis deficiency affects brain substrates of selective attention in childhood-onset growth hormone deficient patients. Neurosci. Lett. 2003, 353:123-126.
41. MacDonald A.W., Cohen J.D., Stenger V.A., Carter C.S. Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. Science 2000, 288(5472):1835-1838.
42. Morley J.E., Kaiser F., Raum W.J., Perry H.M., Flood J.F., Jensen J., Silver A.J., Roberts E. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:7537-7542.
43. Möderscheim T.A.E., Christophidis L.J., Williams C.E., Scheepens A. Distinct neuronal growth hormone receptor ligand specificity in the rat brain. Brain Res. 2007, 1137:29.
44. Müller T., Welnic J., Woitalla D., Muhlack S. Endurance exercise modulates levodopa induced growth hormone release in patients with Parkinson's disease. Neurosci. Lett. 2007, 422:119-122.
45. Nyberg F. Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance. Front. Neuroendocrinol. 2000, 21:330-348.
46. Oertel H., Schneider H., Stalla G., Holsboer F., Zihl J. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism. Psychoneuroendocrinology 2004, 29:839-850.
47. Pagani F., Netti C., Guidobono F., Lattuada N., Ticozzi C., Sibilia V. Effects of amylin and salmon calcitonin on β-endorphin-induced growth hormone and prolactin secretion in the rat. Neuroendocrinology 1998, 68:220-228.
48. Peace K.A., Orme S.M., padayatty S.J., Godfrey H.P.D., Belchetz P.E. Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication. Clin. Endocrinol. 1998, 49(3):391-396.
49. Polich J. P300 clinical utility and control of variability. J. Clin. Neurophysiol. 1998, 15:14-33.
50. Polich J. Theoretical overview of P3a and P3b. Detection of Change: Event-related Potential and fMRI Findings 2003, 83-98. Kluwer Academic, Boston. J. Polich (Ed.).
51. Putman P., Hermans E.J., van Honk J. Exogenous cortisol shifts a motivated bias from fear to anger in spatial working memory for facial expressions. Psychoneuroendocrinology 2007, 32(1):14-21.
52. Salthouse T.A., Fristoe N., McGuthry K.E., Hambrick D.Z. Relation of task switching to speed, age, and fluid intelligence. Psychol. Aging 1998, 13(3):445-461.
53. Samuels M.H., Schuff K.G., Carlson N.E., Carello P., Janowsky J.S. Health status, mood, and cognition in experimentally induced subclinical thyrotoxicosis. J. Clin. Endocrinol. Metab. 2008, 93(5):1730-1736.
54. Sartorio A., Molinari E., Riva G., Conti A., Morabito F., Faglia G. Growth hormone treatment in adults with childhood onset growth hormone deficiency: effects on psychological capabilities. Horm. Res. 1995, 6-11.
55. Sathiavageeswaran M., Burman P., Lawrence D., Harris A., Falleti M., Maruff P., Wass J. Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study. Eur. J. Endocrinol. 2007, 156(4):439-447.
56. Scheepens A., Möderscheim T.A., Gluckman P.D. The role of growth hormone in neural development. Horm. Res. 2005, 64(3):66-72.
57. Segal-Lieberman G., Rubinfeld H., Glick M., Kronfeld-Schor N., Shimon I. Melanin-concentrating hormone stimulates human growth hormone secretion: a novel effect of MCH on the hypothalamic-pituitary axis. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E982-E988.
58. Shaywitz B.A., Shaywitz S.E., Sebrechts M.M., Anderson G.M., Cohen D.J., Jatlow P., Young J.G. Growth hormone and prolactin response to methylphenidate in children with attention deficit disorder. Life Sci. 1990, 46(9):625-633.
59. Soares C.N., Musolino N.R., Cunha N.M., et al. Impact of recombinant human growth hormone. A placebo-controlled trial (RH-GH) treatment on psychiatric, neuropsychological and clinical profiles of GH deficient adults. Arq. Neuropsiquiatr. 1999, 182-189.
60. Sonntag W.E., Ramsey M., Carter C.S. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res. Rev. 2005, 4(2):195-212.
61. Stroop J.R. Studies of interference in serial verbal reactions. J. Exp. Psychol. 1935, 18:643-662.
62. Sullivan R.M., Dufresne M.M. Mesocortical dopamine and HPA axis regulation: Role of laterality and early environment. Brain Res. 2006, 1076:49-59.
63. Tzanela M. Dynamic tests and basal values for defining active acromegaly. Neuroendocrinology 2006, 83(3-4):200-204.
64. van Dam P.S., Aleman A., de Vries W.R., Deijen J.B., Van der Veen E.A., de Haan E.H.F., Koppeschaar H.P.F. Growth hormone, insulin-like growth factor-I and cognitive function in adults. GH IGF-I Res. 2000, 10:S69-S73.
65. van Dam P.S., de Winter C.F., de Vries R., van der Grond J., Drent M.L., Lijffijt M., Kenemans J.L., Aleman A., de Haan E.H., Koppeschaar H.P. Childhood-onset growth hormone deficiency, cognitive function and brain N-acetylaspartate. Psychoneuroendocrinology 2005, 30(4):357-363.
66. van Dam P.S. Somatotropic therapy and cognitive function in adults with growth hormone deficiency: a critical review. Treat Endocrinol. 2006, 5(2):1.
67. van der Reijden-Lakeman I.E., de Sonneville L.M., Swaab-Barneveld H.J., Slijper F.M., Verhulst F.C. Evaluation of attention before and after 2 years of growth hormone treatment in intrauterine growth retarded children. J. Clin. Exp. Neuropsychol. 1997, 19(1):101-118.
68. Very N.M., Sheridan M.A. Somatostatin regulates hepatic growth hormone sensitivity by internalizing growth hormone receptors and by decreasing transcription of growth hormone receptor mRNAs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R1956-R1962.
69. Vitiello M.V., Moe K.E., Merriam G.R., Mazzoni G., Buchner D.H., Schwartz R.S. Growth hormone releasing hormone improves the cognition of healthy older adults. Neurobiol. Aging 2006, 27:318-323.
70. Watson G.S., Baker L.D., Cholerton B.A., Rhoads K.W., Merriam G.R., Schellenberg G.D., Asthana S., Cherrier M., Craft S. Effects of insulin and octreotide on memory and growth hormone in Alzheimer's disease. J. Alzheimers Dis. 2009, (July).
71. Wong A.O.L., Murphy C.K., Chang J.P., Neumann C.M., Lo A., Peter R.E. Direct actions of serotonin on gonadotropin-II and growth hormone release from goldfish pituitary cells: interactions with gonadotropin-releasing hormone and dopamine and further evaluation of serotonin receptor specificity. Fish Physiol. Biochem. 1998, 19(1):23-34.